Loading…
Reported covered position: Policy Director to Rep. Steny Hoyer (95-98)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Food and Drug Administration Safety Over Sequestration Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
FDA Funding, H.R. 1078 FDA Safety Over Sequestration Act, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2016, Administration budget for Fiscal Year 2017
Food and Drug Administration Safety Over Sequestration Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2015 · third_quarter · Q3
H.R. 1890 Bipartisan Congressional Trade Priorities and Accountability Act, S. 995 Bipartisan Congressional Trade Priorities and Accountability Act, Trans-Pacific Partnership
FDA Funding, H.R. 1078 FDA Safety Over Sequestration Act, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2016, Administration budget for Fiscal Year 2017
Source: Senate LDA
FDA Funding, H.R. 1078 FDA Safety Over Sequestration Act, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2016
Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, Issues Regarding Market Exclusivity, Drug Quality and Security Act Implementation, 21st Century Cures Initiative, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, Abuse-Deterrent Prescription Drug Formulations, H.R. 406 Combination Drug Development Incentive Act, H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, H.R. 1576 Generic Complex Drugs Safety and Effectiveness for Patients Act
Bipartisan Congressional Trade Priorities and Accountability Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 1890 Bipartisan Congressional Trade Priorities and Accountability Act, S. 995 Bipartisan Congressional Trade Priorities and Accountability Act
Bipartisan Congressional Trade Priorities and Accountability Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 1890 Bipartisan Congressional Trade Priorities and Accountability Act, S. 995 Bipartisan Congressional Trade Priorities and Accountability Act, Trans-Pacific Partnership
Medicaid Generic Drug Price Fairness Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Medicare Part D Program and Generic Drugs,H.R. 2391 Medicaid Generic Drug Price Fairness Act, S. 1364 Medicaid Generic Drug Price Fairness Act
Medicaid Generic Drug Price Fairness Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Medicare Part D Program and Generic Drugs,H.R. 2391 Medicaid Generic Drug Price Fairness Act, S. 1364 Medicaid Generic Drug Price Fairness Act, Medicare reimbursement for biosimilars
FAST Generics Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA,Labeling of Generic Drugs, Biosimilars Naming, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products, H.R. 6 21st Century Cures Act, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, S. 1421 Orphan Product Extensions Now Accelerating Cures and Treatments Act, H.R. 2841 FAST Generics Act, Dormant Therapies Act, H.R. 3513 Prescription Drug Affordability Act, S. 2023 Prescription Drug Affordability Act
FAST Generics Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA,Labeling of Generic Drugs, Biosimilars Naming, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products, H.R. 6 21st Century Cures Act, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, Abuse-Deterrent Prescription Drug Formulations,H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, S. 1421 Orphan Product Extensions Now Accelerating Cures and Treatments Act,H.R. 2841 FAST Generics Act
Prescription Drug Affordability Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA,Labeling of Generic Drugs, Biosimilars Naming, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products, H.R. 6 21st Century Cures Act, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, S. 1421 Orphan Product Extensions Now Accelerating Cures and Treatments Act, H.R. 2841 FAST Generics Act, Dormant Therapies Act, H.R. 3513 Prescription Drug Affordability Act, S. 2023 Prescription Drug Affordability Act
Combination Drug Development Incentive Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, Issues Regarding Market Exclusivity, Drug Quality and Security Act Implementation, 21st Century Cures Initiative, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, Abuse-Deterrent Prescription Drug Formulations, H.R. 406 Combination Drug Development Incentive Act, H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, H.R. 1576 Generic Complex Drugs Safety and Effectiveness for Patients Act
21st Century Cures Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA,Labeling of Generic Drugs, Biosimilars Naming, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products, H.R. 6 21st Century Cures Act, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, Abuse-Deterrent Prescription Drug Formulations,H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, S. 1421 Orphan Product Extensions Now Accelerating Cures and Treatments Act,H.R. 2841 FAST Generics Act
21st Century Cures Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA,Labeling of Generic Drugs, Biosimilars Naming, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products, H.R. 6 21st Century Cures Act, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, S. 1421 Orphan Product Extensions Now Accelerating Cures and Treatments Act, H.R. 2841 FAST Generics Act, Dormant Therapies Act, H.R. 3513 Prescription Drug Affordability Act, S. 2023 Prescription Drug Affordability Act
Innovation Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Patent Reform, H.R. 9 The Innovation Act, S. 632 STRONG Patents Act
Innovation Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 9 The Innovation Act, S. 632 STRONG Patents Act, S. 1137 Patent Act
Innovation Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 9 The Innovation Act, S. 1137 PATENT Act, S. 2019 Preserve Access to Affordable Generics Act
Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, Issues Regarding Market Exclusivity, Drug Quality and Security Act Implementation, 21st Century Cures Initiative, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, Abuse-Deterrent Prescription Drug Formulations, H.R. 406 Combination Drug Development Incentive Act, H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, H.R. 1576 Generic Complex Drugs Safety and Effectiveness for Patients Act
Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA,Labeling of Generic Drugs, Biosimilars Naming, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products, H.R. 6 21st Century Cures Act, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, S. 1421 Orphan Product Extensions Now Accelerating Cures and Treatments Act, H.R. 2841 FAST Generics Act, Dormant Therapies Act, H.R. 3513 Prescription Drug Affordability Act, S. 2023 Prescription Drug Affordability Act
Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA,Labeling of Generic Drugs, Biosimilars Naming, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products, H.R. 6 21st Century Cures Act, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, Abuse-Deterrent Prescription Drug Formulations,H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, S. 1421 Orphan Product Extensions Now Accelerating Cures and Treatments Act,H.R. 2841 FAST Generics Act
PATENT Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 9 The Innovation Act, S. 632 STRONG Patents Act, S. 1137 Patent Act
PATENT Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 9 The Innovation Act, S. 1137 PATENT Act, S. 2019 Preserve Access to Affordable Generics Act
Medicaid Generic Drug Price Fairness Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Medicare Part D Program and Generic Drugs,H.R. 2391 Medicaid Generic Drug Price Fairness Act, S. 1364 Medicaid Generic Drug Price Fairness Act
Medicaid Generic Drug Price Fairness Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Medicare Part D Program and Generic Drugs,H.R. 2391 Medicaid Generic Drug Price Fairness Act, S. 1364 Medicaid Generic Drug Price Fairness Act, Medicare reimbursement for biosimilars
Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA,Labeling of Generic Drugs, Biosimilars Naming, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products, H.R. 6 21st Century Cures Act, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, S. 1421 Orphan Product Extensions Now Accelerating Cures and Treatments Act, H.R. 2841 FAST Generics Act, Dormant Therapies Act, H.R. 3513 Prescription Drug Affordability Act, S. 2023 Prescription Drug Affordability Act
Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA,Labeling of Generic Drugs, Biosimilars Naming, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products, H.R. 6 21st Century Cures Act, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, Abuse-Deterrent Prescription Drug Formulations,H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, S. 1421 Orphan Product Extensions Now Accelerating Cures and Treatments Act,H.R. 2841 FAST Generics Act
Preserve Access to Affordable Generics Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 9 The Innovation Act, S. 1137 PATENT Act, S. 2019 Preserve Access to Affordable Generics Act
Prescription Drug Affordability Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA,Labeling of Generic Drugs, Biosimilars Naming, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products, H.R. 6 21st Century Cures Act, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, S. 1421 Orphan Product Extensions Now Accelerating Cures and Treatments Act, H.R. 2841 FAST Generics Act, Dormant Therapies Act, H.R. 3513 Prescription Drug Affordability Act, S. 2023 Prescription Drug Affordability Act
STRONG Patents Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Patent Reform, H.R. 9 The Innovation Act, S. 632 STRONG Patents Act
STRONG Patents Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 9 The Innovation Act, S. 632 STRONG Patents Act, S. 1137 Patent Act
Bipartisan Congressional Trade Priorities and Accountability Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 1890 Bipartisan Congressional Trade Priorities and Accountability Act, S. 995 Bipartisan Congressional Trade Priorities and Accountability Act
Bipartisan Congressional Trade Priorities and Accountability Act of 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 1890 Bipartisan Congressional Trade Priorities and Accountability Act, S. 995 Bipartisan Congressional Trade Priorities and Accountability Act, Trans-Pacific Partnership
Medicare Drug Savings Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Affordable Care Act (ACA), Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic Drugs, H.R. 1588 Medicare Drug Savings Act of 2013, H.R. 4160 Keep the Promise to Seniors Act, S. 740 Medicare Drug Savings Act of 2013, S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013
Medicare Drug Savings Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Medicare Part D Program and Generic Drugs, H.R. 1588, Medicare Drug Savings Act of 2013, S. 740, Medicare Drug Savings Act of 2013
Medicare Drug Savings Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Affordable Care Act (ACA), Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic Drugs, H.R. 1588 - Medicare Drug Savings Act of 2013, H.R. 4160 Keep the Promise to Seniors Act, S. 740 - Medicare Drug Savings Act of 2013, S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
FY15 Presidential Budget Request, FY15 House and Senate Financial Services Appropriations, H.R. 2725 Food and Drug Administration Safety over Sequestration Act of 2013, H.R. 2410 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, H.J. Res. 59 Continuing Appropriations Resolution 2014, S. 1413 FDA User Fee Protection ActS. 1244 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Generic Drug User Fees, FDA Funding, FY15 Presidential Budget Request, FY15 House and Senate Financial Services Appropriations, H.R. 2725-Food and Drug Administration Safety over Sequestration Act of 2013, H.R. 2410-Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2014, H.J. Res. 59-Continuing Appropriations Resolution 2014, S. 1413-FDA User Fee Protection Act,S. 1244 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 2725, FDA Safety over Sequestration Act of 2013, H.R. 4800, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015, S. 2389, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015, H.R.5016, Financial Services and General Government Appropriations Act, 2015, S. 1413, FDA User Fee Protection Act, FY2016 FDA Budget Request
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Generic Drug User Fees, FDA Funding, FY15 Presidential Budget Request, FY15 House and Senate Financial Services Appropriations, H.R. 2725-Food and Drug Administration Safety over Sequestration Act of 2013, H.R. 2410-Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2014, H.J. Res. 59-Continuing Appropriations Resolution 2014, S. 1413-FDA User Fee Protection Act,S. 1244 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
FY15 Presidential Budget Request, FY15 House and Senate Financial Services Appropriations, H.R. 2725 Food and Drug Administration Safety over Sequestration Act of 2013, H.R. 2410 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, H.J. Res. 59 Continuing Appropriations Resolution 2014, S. 1413 FDA User Fee Protection ActS. 1244 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,H.R. 3709 - Protecting Consumers Access to Generic Drugs Act of 2013 S. 214 - Preserve Access to Affordable Generics Act S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 2725, FDA Safety over Sequestration Act, S. 1413, FDA User Fee Protection Act, H.R. 2985, Combination Drug Development Incentive Act, H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013, H.R. 486, Stop Tampering of Prescription Pills Act of 2013H.R. 4437, Generic Drug Pricing Fairness Act
Combination Drug Development Incentive Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, H.R. 5657 Fair Access for Safe and Timely Generics Act, H.R. 3116 MODDERN Cures Act, H.R. 2985 Combination Drug Development Incentive Act, H.R. 4437 Generic Drug Pricing Fairness Act, S. 3004 Dormant Therapies Act, Issues Regarding Market Exclusivity, Drug Quality and Security Act Implementation
Combination Drug Development Incentive Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 2725, FDA Safety over Sequestration Act, S. 1413, FDA User Fee Protection Act, H.R. 2985, Combination Drug Development Incentive Act, H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013, H.R. 486, Stop Tampering of Prescription Pills Act of 2013H.R. 4437, Generic Drug Pricing Fairness Act
Combination Drug Development Incentive Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, Generic Drugs Savings, H.R. 5657 Fair Access for Safe and Timely Generics Act, H.R. 3116 MODDERN Cures Act, H.R. 2985 Combination Drug Development Incentive Act, H.R. 4437 Generic Drug Pricing Fairness Act, Issues Regarding Market Exclusivity
MODDERN Cures Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, Generic Drugs Savings, H.R. 5657 Fair Access for Safe and Timely Generics Act, H.R. 3116 MODDERN Cures Act, H.R. 2985 Combination Drug Development Incentive Act, H.R. 4437 Generic Drug Pricing Fairness Act, Issues Regarding Market Exclusivity
MODDERN Cures Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, H.R. 5657 Fair Access for Safe and Timely Generics Act, H.R. 3116 MODDERN Cures Act, H.R. 2985 Combination Drug Development Incentive Act, H.R. 4437 Generic Drug Pricing Fairness Act, S. 3004 Dormant Therapies Act, Issues Regarding Market Exclusivity, Drug Quality and Security Act Implementation
Drug Quality and Security Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,H.R. 3709 - Protecting Consumers Access to Generic Drugs Act of 2013 S. 214 - Preserve Access to Affordable Generics Act S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
Drug Quality and Security Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
Protecting Consumer Access to Generic Drugs Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Patent Reform, H.R. 3309 Innovation Act, H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013, S. 214 - Preserve Access to Affordable Generics Act, S. 1720 Patent Transparency and Improvements Act of 2013, S. 2049 - Transparency in Assertion of Patents Act
Protecting Consumer Access to Generic Drugs Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,H.R. 3709 - Protecting Consumers Access to Generic Drugs Act of 2013 S. 214 - Preserve Access to Affordable Generics Act S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
Protecting Consumer Access to Generic Drugs Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Patent Reform, H.R. 3309 Innovation Act, H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013, S. 214 Preserve Access to Affordable Generics Act, S. 1720 Patent Transparency and Improvements Act of 2013, S. 2049 Transparency in Assertion of Patents Act
Antibiotic Development to Advance Patient Treatment Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 2725, FDA Safety over Sequestration Act, S. 1413, FDA User Fee Protection Act, H.R. 2985, Combination Drug Development Incentive Act, H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013, H.R. 486, Stop Tampering of Prescription Pills Act of 2013H.R. 4437, Generic Drug Pricing Fairness Act
Bipartisan Congressional Trade Priorities Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Trans Pacific Partnership, H.R. 3830 the Bipartisan Congressional Trade Priorities Act, S. 1900 the Bipartisan Congressional Trade Priorities Act
Bipartisan Congressional Trade Priorities Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Free Trade Agreements-Trans Pacific Partnership, TTIP, TPA, H.R. 3830 - the Bipartisan Congressional Trade Priorities Act of 2014, S. 1900 - the Bipartisan Congressional Trade Priorities Act of 2014
Bipartisan Congressional Trade Priorities Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Trans Pacific Partnership, H.R. 3830 the Bipartisan Congressional Trade Priorities Act of 2014, S. 1900 the Bipartisan Congressional Trade Priorities Act of 2014
Bipartisan Congressional Trade Priorities Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Free Trade Agreements-Trans Pacific Partnership, TTIP, TPA, H.R. 3830 the Bipartisan Congressional Trade Priorities Act of 2014, S. 1900 the Bipartisan Congressional Trade Priorities Act of 2014
Keep the Promise to Seniors Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Affordable Care Act (ACA), Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic Drugs, H.R. 1588 Medicare Drug Savings Act of 2013, H.R. 4160 Keep the Promise to Seniors Act, S. 740 Medicare Drug Savings Act of 2013, S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013
Keep the Promise to Seniors Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Affordable Care Act (ACA), Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic Drugs, H.R. 1588 - Medicare Drug Savings Act of 2013, H.R. 4160 Keep the Promise to Seniors Act, S. 740 - Medicare Drug Savings Act of 2013, S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013
Generic Drug Pricing Fairness Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, H.R. 5657 Fair Access for Safe and Timely Generics Act, H.R. 3116 MODDERN Cures Act, H.R. 2985 Combination Drug Development Incentive Act, H.R. 4437 Generic Drug Pricing Fairness Act, S. 3004 Dormant Therapies Act, Issues Regarding Market Exclusivity, Drug Quality and Security Act Implementation
Generic Drug Pricing Fairness Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, Generic Drugs Savings, H.R. 5657 Fair Access for Safe and Timely Generics Act, H.R. 3116 MODDERN Cures Act, H.R. 2985 Combination Drug Development Incentive Act, H.R. 4437 Generic Drug Pricing Fairness Act, Issues Regarding Market Exclusivity
Stop Tampering of Prescription Pills Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
Stop Tampering of Prescription Pills Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 2725, FDA Safety over Sequestration Act, S. 1413, FDA User Fee Protection Act, H.R. 2985, Combination Drug Development Incentive Act, H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013, H.R. 486, Stop Tampering of Prescription Pills Act of 2013H.R. 4437, Generic Drug Pricing Fairness Act
Stop Tampering of Prescription Pills Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,H.R. 3709 - Protecting Consumers Access to Generic Drugs Act of 2013 S. 214 - Preserve Access to Affordable Generics Act S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
Fair Access for Safe and Timely Generics Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, Generic Drugs Savings, H.R. 5657 Fair Access for Safe and Timely Generics Act, H.R. 3116 MODDERN Cures Act, H.R. 2985 Combination Drug Development Incentive Act, H.R. 4437 Generic Drug Pricing Fairness Act, Issues Regarding Market Exclusivity
Fair Access for Safe and Timely Generics Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, H.R. 5657 Fair Access for Safe and Timely Generics Act, H.R. 3116 MODDERN Cures Act, H.R. 2985 Combination Drug Development Incentive Act, H.R. 4437 Generic Drug Pricing Fairness Act, S. 3004 Dormant Therapies Act, Issues Regarding Market Exclusivity, Drug Quality and Security Act Implementation
Medicaid Generic Drug Price Fairness Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Medicare Part D Program and Generic Drugs, H.R. 5748 Medicaid Generic Drug Price Fairness Act, S. 2948 Medicaid Generic Drug Price Fairness Act
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Generic Drug User Fees, FDA Funding, FY15 Presidential Budget Request, FY15 House and Senate Financial Services Appropriations, H.R. 2725-Food and Drug Administration Safety over Sequestration Act of 2013, H.R. 2410-Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2014, H.J. Res. 59-Continuing Appropriations Resolution 2014, S. 1413-FDA User Fee Protection Act,S. 1244 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
FDA User Fee Protection Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 2725, FDA Safety over Sequestration Act, S. 1413, FDA User Fee Protection Act, H.R. 2985, Combination Drug Development Incentive Act, H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013, H.R. 486, Stop Tampering of Prescription Pills Act of 2013H.R. 4437, Generic Drug Pricing Fairness Act
FDA User Fee Protection Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,H.R. 3709 - Protecting Consumers Access to Generic Drugs Act of 2013 S. 214 - Preserve Access to Affordable Generics Act S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
FDA User Fee Protection Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
FY15 Presidential Budget Request, FY15 House and Senate Financial Services Appropriations, H.R. 2725 Food and Drug Administration Safety over Sequestration Act of 2013, H.R. 2410 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, H.J. Res. 59 Continuing Appropriations Resolution 2014, S. 1413 FDA User Fee Protection ActS. 1244 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
FDA User Fee Protection Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Generic Drug User Fees, FDA Funding, FY15 Presidential Budget Request, FY15 House and Senate Financial Services Appropriations, H.R. 2725-Food and Drug Administration Safety over Sequestration Act of 2013, H.R. 2410-Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2014, H.J. Res. 59-Continuing Appropriations Resolution 2014, S. 1413-FDA User Fee Protection Act,S. 1244 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
FDA User Fee Protection Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
FDA User Fee Protection Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 2725, FDA Safety over Sequestration Act of 2013, H.R. 4800, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015, S. 2389, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015, H.R.5016, Financial Services and General Government Appropriations Act, 2015, S. 1413, FDA User Fee Protection Act, FY2016 FDA Budget Request
Patent Transparency and Improvements Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Patent Reform, H.R. 3309 Innovation Act, H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013, S. 214 Preserve Access to Affordable Generics Act, S. 1720 Patent Transparency and Improvements Act of 2013, S. 2049 Transparency in Assertion of Patents Act
Patent Transparency and Improvements Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Patent Reform, H.R. 3309 Innovation Act, H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013, S. 214 - Preserve Access to Affordable Generics Act, S. 1720 Patent Transparency and Improvements Act of 2013, S. 2049 - Transparency in Assertion of Patents Act
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Affordable Care Act (ACA), Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic Drugs, H.R. 1588 - Medicare Drug Savings Act of 2013, H.R. 4160 Keep the Promise to Seniors Act, S. 740 - Medicare Drug Savings Act of 2013, S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Affordable Care Act (ACA), Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic Drugs, H.R. 1588 Medicare Drug Savings Act of 2013, H.R. 4160 Keep the Promise to Seniors Act, S. 740 Medicare Drug Savings Act of 2013, S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013
Bipartisan Congressional Trade Priorities Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Trans Pacific Partnership, H.R. 3830 the Bipartisan Congressional Trade Priorities Act, S. 1900 the Bipartisan Congressional Trade Priorities Act
Bipartisan Congressional Trade Priorities Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Trans Pacific Partnership, H.R. 3830 the Bipartisan Congressional Trade Priorities Act of 2014, S. 1900 the Bipartisan Congressional Trade Priorities Act of 2014
Bipartisan Congressional Trade Priorities Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Free Trade Agreements-Trans Pacific Partnership, TTIP, TPA, H.R. 3830 - the Bipartisan Congressional Trade Priorities Act of 2014, S. 1900 - the Bipartisan Congressional Trade Priorities Act of 2014
Bipartisan Congressional Trade Priorities Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Free Trade Agreements-Trans Pacific Partnership, TTIP, TPA, H.R. 3830 the Bipartisan Congressional Trade Priorities Act of 2014, S. 1900 the Bipartisan Congressional Trade Priorities Act of 2014
Transparency in Assertion of Patents Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Patent Reform, H.R. 3309 Innovation Act, H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013, S. 214 Preserve Access to Affordable Generics Act, S. 1720 Patent Transparency and Improvements Act of 2013, S. 2049 Transparency in Assertion of Patents Act
Transparency in Assertion of Patents Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Patent Reform, H.R. 3309 Innovation Act, H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013, S. 214 - Preserve Access to Affordable Generics Act, S. 1720 Patent Transparency and Improvements Act of 2013, S. 2049 - Transparency in Assertion of Patents Act
Preserve Access to Affordable Generics Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,H.R. 3709 - Protecting Consumers Access to Generic Drugs Act of 2013 S. 214 - Preserve Access to Affordable Generics Act S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
Preserve Access to Affordable Generics Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Patent Reform, H.R. 3309 Innovation Act, H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013, S. 214 Preserve Access to Affordable Generics Act, S. 1720 Patent Transparency and Improvements Act of 2013, S. 2049 Transparency in Assertion of Patents Act
Preserve Access to Affordable Generics Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Patent Reform, H.R. 3309 Innovation Act, H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013, S. 214 - Preserve Access to Affordable Generics Act, S. 1720 Patent Transparency and Improvements Act of 2013, S. 2049 - Transparency in Assertion of Patents Act
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
H.R. 2725, FDA Safety over Sequestration Act of 2013, H.R. 4800, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015, S. 2389, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015, H.R.5016, Financial Services and General Government Appropriations Act, 2015, S. 1413, FDA User Fee Protection Act, FY2016 FDA Budget Request
Medicaid Generic Drug Price Fairness Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Medicare Part D Program and Generic Drugs, H.R. 5748 Medicaid Generic Drug Price Fairness Act, S. 2948 Medicaid Generic Drug Price Fairness Act
Dormant Therapies Act of 2014
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, H.R. 5657 Fair Access for Safe and Timely Generics Act, H.R. 3116 MODDERN Cures Act, H.R. 2985 Combination Drug Development Incentive Act, H.R. 4437 Generic Drug Pricing Fairness Act, S. 3004 Dormant Therapies Act, Issues Regarding Market Exclusivity, Drug Quality and Security Act Implementation
Medicare Drug Savings Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Affordable Care Act (ACA), Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic Drugs, H.R. 1588 Medicare Drug Savings Act of 2013, H.R. 4160 Keep the Promise to Seniors Act, S. 740 Medicare Drug Savings Act of 2013, S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013
Medicare Drug Savings Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Medicare Part D Program and Generic Drugs, H.R. 1588, Medicare Drug Savings Act of 2013, S. 740, Medicare Drug Savings Act of 2013
Medicare Drug Savings Act of 2013
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Affordable Care Act (ACA), Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic Drugs, H.R. 1588 - Medicare Drug Savings Act of 2013, H.R. 4160 Keep the Promise to Seniors Act, S. 740 - Medicare Drug Savings Act of 2013, S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013
Drug Supply Chain Security Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
Drug Supply Chain Security Act
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,H.R. 3709 - Protecting Consumers Access to Generic Drugs Act of 2013 S. 214 - Preserve Access to Affordable Generics Act S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
FY 2014 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Prescription Drug Importation/Re-Importation, Drug Shortages, Pharmaceutical Drug Compounding, Labeling of Generic DrugsH.R.486 - Stop Tampering of Prescription Pills Act of 2013 H.R.1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug. H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013 H.R.1958 - Gray Market Drug Reform and Transparency Act of 2013 H.R.2186 - VALID Compounding Act of 2013 H.R. 3019 SAFE Compounded Drugs Act H.R. 3089 Compounding Clarity Act of 2013 H.R.3204 Drug Quality and Security Act H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H Res - 161 Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs S.214 - Preserve Access to Affordable Generics Act S.504 - Fair and Immediate Release of Generic Drugs Act S.621 - Safe Prescribing Act of 2013 S 957 - Drug Supply Chain Security Act S 959 - Pharmaceutical Quality, Security, and Accountability Act
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
FY 2014 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Prescription Drug Importation/Re-Importation, Drug Shortages, And Generic Drugs, Pharmaceutical Drug CompoundingH.R. 486 - Stop Tampering of Prescription Pills Act of 2013 H.R. 1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013 H.R. 1958 - Gray Market Drug Reform and Transparency Act of 2013 H.R. 2186 - VALID Compounding Act of 2013 H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H. Res. - 161 Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs S.214 - Preserve Access to Affordable Generics Act S. 504 - Fair and Immediate Release of Generic Drugs Act S. 621 - Safe Prescribing Act of 2013 S. 957 - Drug Supply Chain Security Act S. 959 - Pharmaceutical Compounding S. Res. 97 - A resolution expressing the sense of the Senate that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY14 Presidential Budget Request, FY14 BudgetBills: H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Implementation of Health Care Reform, Implementation of Generic Biologics, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar NamingH.R.486 - Stop Tampering of Prescription Pills Act of 2013 H.R.1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug. H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013 H.R.1958 - Gray Market Drug Reform and Transparency Act of 2013 H.R.2186 - VALID Compounding Act of 2013 H.R. 2725 FDA Safety over Sequestration Act H.R. 3019 SAFE Compounded Drugs Act H.R. 3089 Compounding Clarity Act of 2013 H.R. 3204 Drug Quality and Security Act H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013 H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H Res - 161 Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs S.214 - Preserve Access to Affordable Generics Act S.504 - Fair and Immediate Release of Generic Drugs Act S.621 - Safe Prescribing Act of 2013 S 957 - Drug Supply Chain Security Act S 959 - Pharmaceutical Quality, Security, and Accountability Act
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: ASSOCIATION FOR ACCESSIBLE MEDICINES · Firm: ASSOCIATION FOR ACCESSIBLE MEDICINES
Bills: H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023; H.R. 2725 FDA Safety over Sequestration Act; H.J. Res 59 Continuing Appropriations Resolution 2014; S 1413 FDA User Fee Protection Act; HR 2410 Agriculture, Rural Development, Food Drug Administration Appropriations Act 2014;S 1244 Agriculture, Rural Development, Food Drug Administration Appropriations Act 2014 FY 2014 Budget
H.R. 9 The Innovation Act, S. 1137 PATENT Act, S. 2019 Preserve Access to Affordable Generics Act
Implementation of FDASIA and GDUFA,Labeling of Generic Drugs, Biosimilars Naming, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products, H.R. 6 21st Century Cures Act, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, S. 1421 Orphan Product Extensions Now Accelerating Cures and Treatments Act, H.R. 2841 FAST Generics Act, Dormant Therapies Act, H.R. 3513 Prescription Drug Affordability Act, S. 2023 Prescription Drug Affordability Act
Medicare Part D Program and Generic Drugs,H.R. 2391 Medicaid Generic Drug Price Fairness Act, S. 1364 Medicaid Generic Drug Price Fairness Act, Medicare reimbursement for biosimilars
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2015 · second_quarter · Q2
FDA Funding, H.R. 1078 FDA Safety Over Sequestration Act, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for Fiscal Year 2016
Medicare Part D Program and Generic Drugs,H.R. 2391 Medicaid Generic Drug Price Fairness Act, S. 1364 Medicaid Generic Drug Price Fairness Act
Implementation of FDASIA and GDUFA,Labeling of Generic Drugs, Biosimilars Naming, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products, H.R. 6 21st Century Cures Act, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, Abuse-Deterrent Prescription Drug Formulations,H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, S. 1421 Orphan Product Extensions Now Accelerating Cures and Treatments Act,H.R. 2841 FAST Generics Act
H.R. 9 The Innovation Act, S. 632 STRONG Patents Act, S. 1137 Patent Act
H.R. 1890 Bipartisan Congressional Trade Priorities and Accountability Act, S. 995 Bipartisan Congressional Trade Priorities and Accountability Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2015 · first_quarter · Q1
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, Issues Regarding Market Exclusivity, Drug Quality and Security Act Implementation, 21st Century Cures Initiative, Innovation for Healthier Americans Initiative, Prescription Drug Pricing, Abuse-Deterrent Prescription Drug Formulations, H.R. 406 Combination Drug Development Incentive Act, H.R. 971 Orphan Product Extensions Now Accelerating Cures and Treatments Act, H.R. 1576 Generic Complex Drugs Safety and Effectiveness for Patients Act
Patent Reform, H.R. 9 The Innovation Act, S. 632 STRONG Patents Act
Trans Pacific Partnership, Trade Promotion Authority
Medicare Part D Program and Generic Drugs, Medicare Part D Non-Interference, Prescription Drug Pricing, Low-Income Subsidy in Part D
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2014 · fourth_quarter · Q4
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, H.R. 5657 Fair Access for Safe and Timely Generics Act, H.R. 3116 MODDERN Cures Act, H.R. 2985 Combination Drug Development Incentive Act, H.R. 4437 Generic Drug Pricing Fairness Act, S. 3004 Dormant Therapies Act, Issues Regarding Market Exclusivity, Drug Quality and Security Act Implementation
H.R. 83 Consolidated and Further Continuing Appropriations Act
Medicare Part D Program and Generic Drugs, H.R. 5748 Medicaid Generic Drug Price Fairness Act, S. 2948 Medicaid Generic Drug Price Fairness Act
Trans Pacific Partnership, H.R. 3830 the Bipartisan Congressional Trade Priorities Act, S. 1900 the Bipartisan Congressional Trade Priorities Act
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2014 · third_quarter · Q3
H.R. 4800 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act
Trans Pacific Partnership, H.R. 3830 the Bipartisan Congressional Trade Priorities Act of 2014, S. 1900 the Bipartisan Congressional Trade Priorities Act of 2014
Medicare Part D Program and Generic Drugs
Implementation of FDASIA and GDUFA, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation and Mitigation Strategies, Biosimilars Naming, Electronic Labeling for Pharmaceuticals, Generic Drugs Savings, H.R. 5657 Fair Access for Safe and Timely Generics Act, H.R. 3116 MODDERN Cures Act, H.R. 2985 Combination Drug Development Incentive Act, H.R. 4437 Generic Drug Pricing Fairness Act, Issues Regarding Market Exclusivity
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2014 · second_quarter · Q2
Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 2725, FDA Safety over Sequestration Act, S. 1413, FDA User Fee Protection Act, H.R. 2985, Combination Drug Development Incentive Act, H.R. 3742, Antibiotic Development to Advance Patient Treatment Act of 2013, H.R. 486, Stop Tampering of Prescription Pills Act of 2013H.R. 4437, Generic Drug Pricing Fairness Act
Medicare Part D Program and Generic Drugs, H.R. 1588, Medicare Drug Savings Act of 2013, S. 740, Medicare Drug Savings Act of 2013
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2014 · first_quarter · 1A
Implementation of Affordable Care Act (ACA), Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic Drugs, H.R. 1588 Medicare Drug Savings Act of 2013, H.R. 4160 Keep the Promise to Seniors Act, S. 740 Medicare Drug Savings Act of 2013, S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013
FY15 Presidential Budget Request, FY15 House and Senate Financial Services Appropriations, H.R. 2725 Food and Drug Administration Safety over Sequestration Act of 2013, H.R. 2410 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014, H.J. Res. 59 Continuing Appropriations Resolution 2014, S. 1413 FDA User Fee Protection ActS. 1244 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2014 · first_quarter · Q1
Patent Reform, H.R. 3309 Innovation Act, H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013, S. 214 - Preserve Access to Affordable Generics Act, S. 1720 Patent Transparency and Improvements Act of 2013, S. 2049 - Transparency in Assertion of Patents Act
Free Trade Agreements-Trans Pacific Partnership, TTIP, TPA, H.R. 3830 - the Bipartisan Congressional Trade Priorities Act of 2014, S. 1900 - the Bipartisan Congressional Trade Priorities Act of 2014
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,H.R. 3709 - Protecting Consumers Access to Generic Drugs Act of 2013 S. 214 - Preserve Access to Affordable Generics Act S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2013 · fourth_quarter · Q4
S. 214 - Preserve Access to Affordable Generics Act; S.504 - Fair and Immediate Release of Generic Drugs Act, H.R. 3309 Innovation Act, HR 3709 Protecting Consumers Access to Generic Drugs Act of 2013
Free Trade Agreements-Trans Pacific Partnership
Implementation of Health Care Reform, Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D ProgramH. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H.R. 1588 - Medicare Drug Savings Act of 2013 S.740 - Medicare Drug Savings Act of 2013 S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2013 · third_quarter · Q3
Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY14 Presidential BudgetH. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H.R. 2725 FDA Safety over Sequestration Act S. 1413 FDA User Fee Protection Act HR 2410 Agriculture, Rural Development, Food Drug Administration Appropriations Act 2014 S 1244 Agriculture, Rural Development, Food Drug Administration Appropriations Act 2014
FY 2014 Budget, Implementation of Health Care Reform, Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic DrugsH. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H.R. 1588 - Medicare Drug Savings Act of 2013 S.740 - Medicare Drug Savings Act of 2013
ASSOCIATION FOR ACCESSIBLE MEDICINES via ASSOCIATION FOR ACCESSIBLE MEDICINES
2013 · second_quarter · Q2
Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent Term Extensions, Generic DrugsBills: H.R.486 - Stop Tampering of Prescription Pills Act of 2013 H.R.1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug S.214 - Preserve Access to Affordable Generics Act S.504 - Fair and Immediate Release of Generic Drugs Act S.621 - Safe Prescribing Act of 2013
FY 2014 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Prescription Drug Importation/Re-Importation, Drug Shortages, And Generic Drugs, Pharmaceutical Drug CompoundingH.R. 486 - Stop Tampering of Prescription Pills Act of 2013 H.R. 1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013 H.R. 1958 - Gray Market Drug Reform and Transparency Act of 2013 H.R. 2186 - VALID Compounding Act of 2013 H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H. Res. - 161 Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs S.214 - Preserve Access to Affordable Generics Act S. 504 - Fair and Immediate Release of Generic Drugs Act S. 621 - Safe Prescribing Act of 2013 S. 957 - Drug Supply Chain Security Act S. 959 - Pharmaceutical Compounding S. Res. 97 - A resolution expressing the sense of the Senate that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs
H.R. 2725, FDA Safety over Sequestration Act of 2013, H.R. 4800, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015, S. 2389, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015, H.R.5016, Financial Services and General Government Appropriations Act, 2015, S. 1413, FDA User Fee Protection Act, FY2016 FDA Budget Request
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
Implementation of Biosimilars in the Affordable Care Act (ACA), Implementation of FDASIA and GDUFA, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar Naming, Electronic Labeling for Pharmaceuticals, H.R. 486 - Stop Tampering of Prescription Pills Act of 2013, H.R. 2725 - FDA Safety over Sequestration Act, H.R. 3204 - Drug Quality and Security Act,S. 957 - Drug Supply Chain Security Act S. 1413 FDA User Fee Protection Act
Patent Reform, H.R. 3309 Innovation Act, H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013, S. 214 Preserve Access to Affordable Generics Act, S. 1720 Patent Transparency and Improvements Act of 2013, S. 2049 Transparency in Assertion of Patents Act
Free Trade Agreements-Trans Pacific Partnership, TTIP, TPA, H.R. 3830 the Bipartisan Congressional Trade Priorities Act of 2014, S. 1900 the Bipartisan Congressional Trade Priorities Act of 2014
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, Vice President of the U.S., White House Office
Generic Drug User Fees, FDA Funding, FY15 Presidential Budget Request, FY15 House and Senate Financial Services Appropriations, H.R. 2725-Food and Drug Administration Safety over Sequestration Act of 2013, H.R. 2410-Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act 2014, H.J. Res. 59-Continuing Appropriations Resolution 2014, S. 1413-FDA User Fee Protection Act,S. 1244 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
Implementation of Affordable Care Act (ACA), Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic Drugs, H.R. 1588 - Medicare Drug Savings Act of 2013, H.R. 4160 Keep the Promise to Seniors Act, S. 740 - Medicare Drug Savings Act of 2013, S. 1871 SGR Repeal and Medicare Beneficiary Access Act of 2013
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of the Vice President of the United States, SENATE, U.S. Trade Representative (USTR), White House Office
Implementation of Health Care Reform, Implementation of Generic Biologics, Counterfeit Drugs/Import Safety, Prescription Drug Importation/Re-Importation, Drug Shortages, Labeling of Generic Drugs, Risk Evaluation Mitigation Strategies, Biosimilar NamingH.R.486 - Stop Tampering of Prescription Pills Act of 2013 H.R.1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug. H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013 H.R.1958 - Gray Market Drug Reform and Transparency Act of 2013 H.R.2186 - VALID Compounding Act of 2013 H.R. 2725 FDA Safety over Sequestration Act H.R. 3019 SAFE Compounded Drugs Act H.R. 3089 Compounding Clarity Act of 2013 H.R. 3204 Drug Quality and Security Act H.R. 3709 Protecting Consumers Access to Generic Drugs Act of 2013 H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H Res - 161 Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs S.214 - Preserve Access to Affordable Generics Act S.504 - Fair and Immediate Release of Generic Drugs Act S.621 - Safe Prescribing Act of 2013 S 957 - Drug Supply Chain Security Act S 959 - Pharmaceutical Quality, Security, and Accountability Act
Bills: H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023; H.R. 2725 FDA Safety over Sequestration Act; H.J. Res 59 Continuing Appropriations Resolution 2014; S 1413 FDA User Fee Protection Act; HR 2410 Agriculture, Rural Development, Food Drug Administration Appropriations Act 2014;S 1244 Agriculture, Rural Development, Food Drug Administration Appropriations Act 2014 FY 2014 Budget
Filing targets: Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE
Free Trade Agreements-Trans Pacific Partnership, Generic medicines
FY 2014 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Prescription Drug Importation/Re-Importation, Drug Shortages, Pharmaceutical Drug Compounding, Labeling of Generic DrugsH.R.486 - Stop Tampering of Prescription Pills Act of 2013 H.R.1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug. H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013 H.R.1958 - Gray Market Drug Reform and Transparency Act of 2013 H.R.2186 - VALID Compounding Act of 2013 H.R. 3019 SAFE Compounded Drugs Act H.R. 3089 Compounding Clarity Act of 2013 H.R.3204 Drug Quality and Security Act H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H Res - 161 Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs S.214 - Preserve Access to Affordable Generics Act S.504 - Fair and Immediate Release of Generic Drugs Act S.621 - Safe Prescribing Act of 2013 S 957 - Drug Supply Chain Security Act S 959 - Pharmaceutical Quality, Security, and Accountability Act
S.214 - Preserve Access to Affordable Generics Act S.504 - Fair and Immediate Release of Generic Drugs Act
Filing targets: Congressional Budget Office (CBO), Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE
FY 2014 Budget, Implementation of Health Care Reform, Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic DrugsH. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H.R. 1588 - Medicare Drug Savings Act of 2013 S.740 - Medicare Drug Savings Act of 2013
Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY14 Presidential Budget Request, FY14 BudgetBills: H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023
Free Trade Agreements-Trans Pacific Partnership, Generic Medicines
Filing targets: Congressional Budget Office (CBO), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE, U.S. Trade Representative (USTR)